rs35462421
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP3BP4_StrongBP6_Very_StrongBS1BS2
The NM_004544.4(NDUFA10):c.712G>A(p.Glu238Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00635 in 1,613,638 control chromosomes in the GnomAD database, including 48 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_004544.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00570 AC: 868AN: 152176Hom.: 3 Cov.: 32
GnomAD3 exomes AF: 0.00579 AC: 1456AN: 251482Hom.: 7 AF XY: 0.00601 AC XY: 817AN XY: 135908
GnomAD4 exome AF: 0.00642 AC: 9384AN: 1461344Hom.: 45 Cov.: 30 AF XY: 0.00644 AC XY: 4684AN XY: 727014
GnomAD4 genome AF: 0.00570 AC: 868AN: 152294Hom.: 3 Cov.: 32 AF XY: 0.00533 AC XY: 397AN XY: 74462
ClinVar
Submissions by phenotype
not provided Benign:4
- -
- -
- -
NDUFA10: BS2 -
Leigh syndrome Benign:3
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -
- -
The NDUFA10 p.E238K variant was not identified in the literature but was identified in dbSNP (ID: rs35462421) and ClinVar (classified as likely benign by Invitae and three other laboratories; and as benign by GeneDx and Illumina). The variant was identified in control databases in 1601 of 282886 chromosomes (7 homozygous) at a frequency of 0.005660, and was observed at the highest frequency in the European (non-Finnish) population in 1009 of 129192 chromosomes (5 homozygous) (freq: 0.007810) (Genome Aggregation Database March 6, 2019, v2.1.1). The p.E238 residue is conserved in mammals and computational analyses (MUT Assesor, PolyPhen-2, SIFT, MutationTaster, Revel, FATHMM, MetaLR, DANN) suggest that the variant may impact the protein; however this is not predictive enough to assume pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (Splice AI exome) do not predict a difference in splicing. In summary, based on the above information this variant meets our laboratory's criteria to be classified as benign. -
not specified Benign:1
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Mitochondrial complex 1 deficiency, nuclear type 22 Benign:1
- -
Mitochondrial complex I deficiency, nuclear type 1 Benign:1
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at